UPDATE: ProQR Therapeutics (PRQR) Downgraded to Hold at Stifel, PT Slashed to $3, sepofarsen Revenues Removed From Model

February 11, 2022 11:31 AM EST Send to a Friend
(Updated - February 11, 2022 11:33 AM EST)Stifel analyst Dae Gon Ha downgraded ProQR Therapeutics N.V. (NASDAQ: PRQR) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login